SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

H.C. Wainwright Maintains Buy on Madrigal Pharmaceuticals, Lowers Price Target to $168

H.C. Wainwright maintains Madrigal Pharmaceuticals (NASDAQ:MDGL) with a Buy and lowers the price target from $215 to $168.

Benzinga · 05/08/2020 15:47

H.C. Wainwright maintains Madrigal Pharmaceuticals (NASDAQ:MDGL) with a Buy and lowers the price target from $215 to $168.